Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Incyte Corporation (INCY) vs Nebius Group NV (NBIS) Price & Performance

Incyte CorporationTrade
Nebius Group NVTrade

Price performance (Past 24H)

Key statistics

Incyte Corporation vs Nebius Group NV — how do they compare? Incyte Corporation trades at $115.7 (market cap $23.11B), while Nebius Group NV trades at $219.11 (market cap $46.37B). The key difference: Nebius Group NV is far larger — about 2× Incyte Corporation's market cap, and Incyte Corporation is trading nearer its 52-week high, Nebius Group NV nearer its low. Which is the better fit depends on your goals.

INCYNBIS
Market Cap
$23.11B$46.37B
Sector
HealthTechnology
52-Week High
$118.52$286.69
52-Week Low
$67.38$50.40
Enterprise Value
$19.13B$46.56B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Incyte Corporation

Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.

Read more on INCY

About Nebius Group NV

Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.

Read more on NBIS